文献速递关节外科

全膝关节置换术后关节周围注射混合镇痛方案的随机对照试验系统综述

Periarticular Injection Cocktails for Pain Management After Total Knee Arthroplasty: A Systematic Review of Randomized Controlled Trials.
PubMed 文献 · J Arthroplasty · 2026-09-21

该系统综述纳入78项随机对照试验共8515例患者,评估全膝关节置换术后关节周围浸润镇痛的多模式药物混合方案。与安慰剂相比,混合方案持续减轻术后疼痛、减少阿片类药物消耗并改善早期功能结局;与神经阻滞相比镇痛效果总体相当。含皮质类固醇的混合方案与更好镇痛相关,但方案异质性阻碍确定单一最优配方。

要点

  • 与安慰剂相比,关节周围混合镇痛方案可减轻疼痛、减少阿片消耗并改善早期功能。
  • 与神经阻滞相比镇痛效果总体相当,阿片消耗略偏向神经阻滞。
  • 含皮质类固醇的混合方案与更好镇痛相关,但无一致最优配方。

核心结论

  • 多模式关节周围浸润镇痛改善全膝关节置换术后早期结局,尤其相对于安慰剂。
  • 含皮质类固醇的混合方案可能提供额外获益,但配方、剂量和结局的变异阻碍确定单一最优方案。
  • 脂质体布比卡因是有前景的成分,部分研究显示更好镇痛、更低阿片使用和更高患者满意度。

研究设计与样本

  • 按照PRISMA指南进行的系统综述,检索PubMed、Embase和Cochrane Central Register of Controlled Trials自建库至2025年6月1日的随机对照试验。
  • 纳入比较多模式关节周围浸润混合方案与安慰剂、神经阻滞或替代混合方案并报告临床或经济结局的研究。
  • 采用双人独立筛选、数据提取和Jadad量表偏倚风险评估,最终纳入78项随机对照试验共8515例患者。

主要发现

  • 与安慰剂相比,关节周围混合方案持续减轻术后疼痛、减少阿片消耗并改善早期功能结局。
  • 与神经阻滞相比,疼痛控制总体相当,但阿片使用略偏向神经阻滞。
  • 不同混合配方之间的头对头比较未显示一致更优的组合,但含皮质类固醇的混合方案与更好镇痛相关。
  • 脂质体布比卡因在多数研究中与标准混合方案和神经阻滞效果相当,若干试验报告在镇痛、阿片节省和患者满意度方面有有意义的获益。
  • 仅一项研究报告脂质体布比卡因比收肌管阻滞更具成本效益。

关键数值与推荐

  • 纳入78项随机对照试验,共8515例患者。
  • 证据等级为Level I。
  • 研究异质性限制了汇总分析和直接配方比较。

临床怎么用

  • 全膝关节置换术后可考虑使用多模式关节周围浸润混合方案以改善早期镇痛和减少阿片消耗。
  • 含皮质类固醇的混合方案可能提供额外镇痛获益,但需注意配方差异。
  • 脂质体布比卡因可作为有前景的成分,部分研究显示镇痛、阿片节省和满意度获益。

局限性

  • 研究异质性限制了汇总分析和直接配方比较。
  • 配方、剂量和结局的变异阻碍确定单一最优方案。
  • 仍需标准化、高质量且包含经济结局的试验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Total knee arthroplasty (TKA) is a common and effective treatment for end-stage knee osteoarthritis, but postoperative pain remains a major barrier to recovery and may increase opioid use. Periarticular infiltration (PAI) with multimodal drug cocktails is a promising analgesic strategy, though the optimal formulation remains unclear. METHODS: A systematic review was conducted in accordance with the Preferred Reporting Items for Systematic reviews and Meta-Analyses guidelines. PubMed, Embase, and Cochrane Central Register of Controlled Trials were searched from inception through June 1, 2025, for randomized controlled trials evaluating local infiltration analgesia in TKA. Studies were included if they compared multimodal PAI cocktails to placebo, nerve blocks, or alternative cocktails and reported clinical or economic outcomes. Dual-independent screening, data extraction, and risk of bias assessment (using the Jadad scale) were performed. There were 78 randomized controlled trials comprising 8,515 patients that met the inclusion criteria. RESULTS: Compared to placebo, PAI cocktails consistently reduced postoperative pain and opioid consumption and improved early functional outcomes. In comparisons with nerve blocks, pain control was generally equivalent, though opioid use slightly favored nerve blocks. Head-to-head comparisons between different cocktail formulations showed no consistently superior combination, though cocktails containing corticosteroids were associated with improved analgesia. Liposomal bupivacaine (LB) demonstrated comparable effectiveness to standard cocktails and nerve blocks in most studies, with several trials reporting meaningful benefits in pain reduction, opioid sparing, and patient satisfaction. Only one study reported LB to be more cost-effective than the adductor canal block. Study heterogeneity limited pooled analysis and direct formulation comparisons. CONCLUSIONS: Multimodal PAI improves early postoperative outcomes after TKA, especially versus placebo. Corticosteroid-containing cocktails may provide added benefit, but variation in formulations, dosing, and outcomes prevents the identification of a single optimal regimen. The LB is a promising component, with some studies showing better pain control, lower opioid use, and higher patient satisfaction. Standardized, high-quality trials with economic endpoints are still needed. LEVEL OF EVIDENCE: Level I.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Ng MK, Mastrokostas LE, Mastrokostas PG, et al. Periarticular Injection Cocktails for Pain Management After Total Knee Arthroplasty: A Systematic Review of Randomized Controlled Trials. J Arthroplasty. 2026. PMID: 42767519. doi:10.1016/j.arth.2026.09.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。